1-3 of 3
pathologic bone demineralization
Close
Sort by
Journal Articles

Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry

Marcio Andrade-Campos, PhD, Pilar Irun, PhD, Mercedes Roca-Espiau, PhD, Pilar Giraldo, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3571.
https://doi.org/10.1182/blood.V130.Suppl_1.3571.3571
Published: 2017
Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD
Journal: Blood
Blood (2016) 128 (22): 3438.
https://doi.org/10.1182/blood.V128.22.3438.3438
Published: 2016
Journal Articles

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Akif S. Yavuz, Nilüfer Alpay, Öner Dogan, Nesimi Büyükbabani, Can Baykal, Dilsad Sindel, Yüksel Pekçelen, Refik Tanakol
Journal: Blood
Blood (2007) 110 (11): 4662.
https://doi.org/10.1182/blood.V110.11.4662.4662
Published: 2007